These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 19216621

  • 1. Telomerase-specific virotherapy for human squamous cell carcinoma.
    Fujiwara T.
    Expert Opin Biol Ther; 2009 Mar; 9(3):321-9. PubMed ID: 19216621
    [Abstract] [Full Text] [Related]

  • 2. Telomerase-specific virotheranostics for human head and neck cancer.
    Kurihara Y, Watanabe Y, Onimatsu H, Kojima T, Shirota T, Hatori M, Liu D, Kyo S, Mizuguchi H, Urata Y, Shintani S, Fujiwara T.
    Clin Cancer Res; 2009 Apr 01; 15(7):2335-43. PubMed ID: 19318473
    [Abstract] [Full Text] [Related]

  • 3. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
    Fujiwara T, Urata Y, Tanaka N.
    Curr Cancer Drug Targets; 2007 Mar 01; 7(2):191-201. PubMed ID: 17346111
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic interaction of telomerase-specific oncolytic virotherapy and chemotherapeutic agents for human cancer.
    Fujiwara T, Kagawa S, Tazawa H.
    Curr Pharm Biotechnol; 2012 Jul 01; 13(9):1809-16. PubMed ID: 21740362
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
    Fujiwara T, Urata Y, Tanaka N.
    Front Biosci; 2008 Jan 01; 13():1881-6. PubMed ID: 17981675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Theranostic application of telomerase-specific oncolytic adenovirus for human cancer].
    Fujiwara T, Tanaka N.
    Nihon Rinsho; 2007 Oct 01; 65(10):1913-22. PubMed ID: 17926546
    [Abstract] [Full Text] [Related]

  • 12. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
    Toivonen R, Suominen E, Grenman R, Savontaus M.
    Oncol Rep; 2009 Jan 01; 21(1):165-71. PubMed ID: 19082458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of telomelysin (OBP-301) in mouse xenografts of human head and neck cancer.
    Nakajima O, Ichimaru D, Urata Y, Fujiwara T, Horibe T, Kohno M, Kawakami K.
    Oncol Rep; 2009 Nov 01; 22(5):1039-43. PubMed ID: 19787218
    [Abstract] [Full Text] [Related]

  • 19. In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy.
    Kojima T, Watanabe Y, Hashimoto Y, Kuroda S, Yamasaki Y, Yano S, Ouchi M, Tazawa H, Uno F, Kagawa S, Kyo S, Mizuguchi H, Urata Y, Tanaka N, Fujiwara T.
    Ann Surg; 2010 Jun 01; 251(6):1079-86. PubMed ID: 20485131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.